Atorvastatin 40mg

DRUG14 trials

Sponsors

Chong Kun Dang Pharmaceutical, Yonsei University, Albany Medical College, Boryung Pharmaceutical Co., Ltd, Vestre Viken Hospital Trust

Conditions

Atherosclerotic Cardiovascular Disease With DyslipidemiaCOVID-19Chronic MigraineCoronary Artery DiseaseEpisodic MigraineEssential HypertensionEssential Hypertension, DyslipidemiaHyperlipidemia

Phase 1

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

CompletedNCT01842256

Chong Kun Dang PharmaceuticalEssential Hypertension, Hyperlipidemia

Start: 2013-04-30End: 2013-07-31Updated: 2013-08-01

High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study

WithdrawnNCT03188978

Albany Medical CollegePrimary Arteriovenous Fistula Failure

Start: 2018-11-01End: 2019-12-31Updated: 2020-01-18

Phase 2

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

RecruitingNCT04147286

University of Cape TownTuberculosis, Pulmonary

Start: 2020-07-14End: 2027-09-30Target: 220Updated: 2024-08-23

Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

CompletedNCT05895123

Damanhour UniversityST-segment Elevation Myocardial Infarction

Start: 2021-11-01End: 2023-04-01Updated: 2024-08-01

ATORvastatin in Pulmonary TUBerculosis

RecruitingNCT06199921

Obafemi Awolowo University Teaching HospitalKoch's Disease, Pulmonary Tuberculosis, Tuberculosis

Start: 2024-01-03End: 2026-09-30Target: 440Updated: 2025-09-25

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

RecruitingNCT06248671

St. Olavs HospitalEpisodic Migraine

Start: 2024-05-01End: 2029-02-28Target: 450Updated: 2026-02-19

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

RecruitingNCT06485336

St. Olavs HospitalChronic Migraine

Start: 2024-05-01End: 2029-02-28Target: 300Updated: 2025-07-01

Phase 3

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia

CompletedNCT03338426

Boryung Pharmaceutical Co., LtdEssential Hypertension, Dyslipidemia

Start: 2018-01-15End: 2019-04-22Updated: 2019-11-05

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Moderate and Moderate-to-severe Stroke

RecruitingNCT06358313

Kafrelsheikh UniversityIschemic Stroke

Start: 2024-04-10End: 2025-12-30Target: 600Updated: 2025-09-05

Phase 4

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

CompletedNCT01856374

Yonsei UniversityMulti-vessel Diseases, Angina

Start: 2011-08-31End: 2014-10-31Updated: 2016-07-27

MUscle Side-Effects of Atorvastatin in Coronary Patients

CompletedNCT03874156

Vestre Viken Hospital TrustStatin Adverse Reaction

Start: 2019-03-05End: 2019-12-12Updated: 2020-01-03

Effect of Ezetimibe on Gut Microbiota

RecruitingNCT06784557

Yonsei UniversityAtherosclerotic Cardiovascular Disease With Dyslipidemia

Start: 2024-02-28End: 2025-10-01Target: 110Updated: 2025-01-20

Unknown Phase

COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial

CompletedNCT02155530

Yonsei UniversityCoronary Artery Disease

Start: 2014-06-30End: 2016-06-30Updated: 2016-07-27

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

TerminatedNCT04333407

Imperial College LondonCOVID-19

Start: 2020-04-03End: 2021-11-30Updated: 2023-01-18

Related Papers

Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction.

2024-09-121 citations

PA-543 Evaluation of host serum biomarkers from successfully treated TB patients presenting with or without persisting lung inflammation – preliminary findings of StatinTB trial

2023-12-01

OA-451 Spirometry, diffusion capacity, absolute lung volumes and PET/CT findings upon completion of tuberculosis treatment – preliminary findings of StatinTB/ExtendTB trial

2023-12-01

PA-514 Immunomodulatory activities of atorvastatin on PBMCs from successfully treated TB patients presenting with or without persisting lung inflammation – preliminary findings of StatinTB trial

2023-12-01

DLCO, spirometry and PET/CT findings after completing tuberculosis treatment - preliminary findings of StatinTB/ExtendTB trial

2023-09-09

Lung function impairment after completing tuberculosis therapy - preliminary findings of StatinTB/ExtendTB

2023-09-09

Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment – preliminary findings of participants co-enrolled into the StatinTB trial and Cardiac Imaging After TB (CIA-TB) study

European Heart Journal2022-10-012 citations

Spirometry, DLCO, lung volumes and PET/CT findings after completion of tuberculosis treatment - preliminary findings of the StatinTB trial

2022-09-04

COVID-19 and atherosclerosis: looking beyond the acute crisis

Emergency and Critical Care Medicine2022-01-2710 citations

Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial.

2021-12-2028 citations